{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:13:17Z","timestamp":1791216797383,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.2119\/molmed.2010.00067","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T14:55:12Z","timestamp":1289400912000},"page":"552-557","source":"Crossref","is-referenced-by-count":96,"title":["Interleukin-1\u03b2 and Interleukin-6 in Arthritis Animal Models: Roles in the Early Phase of Transition from Acute to Chronic Inflammation and Relevance for Human Rheumatoid Arthritis"],"prefix":"10.1186","volume":"16","author":[{"given":"Gianfranco","family":"Ferraccioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Bracci-Laudiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alivernini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tolusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"1611552_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","volume":"29","author":"FM Brennan","year":"1989","unstructured":"Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet. 29:244\u20137.","journal-title":"Lancet"},{"key":"1611552_CR2","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer J, et al. (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J.; 10:4025\u201331.","journal-title":"EMBO J."},{"key":"1611552_CR3","doi-asserted-by":"publisher","first-page":"8222","DOI":"10.1073\/pnas.95.14.8222","volume":"95","author":"S Ohshima","year":"1998","unstructured":"Ohshima S, et al. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. U. S. A. 95:8222\u20136.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1611552_CR4","doi-asserted-by":"publisher","first-page":"R445","DOI":"10.1186\/ar1689","volume":"7","author":"D Pohlers","year":"2005","unstructured":"Pohlers D, et al. (2005) Expression of cytokine mRNA and protein in joints and lymphoid organs during the course of rat antigen-induced arthritis. Arthritis Res. Ther. 7:R445\u20137.","journal-title":"Arthritis Res. Ther."},{"key":"1611552_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/jaut.2001.0534","volume":"17","author":"J Simon","year":"2001","unstructured":"Simon J, et al. (2001) Systemic macrophage activation in locally-induced experimental arthritis. J. Autoimmun. 17:127\u201336.","journal-title":"J. Autoimmun."},{"key":"1611552_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1006\/cyto.1999.0502","volume":"11","author":"A Boe","year":"1999","unstructured":"Boe Al, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescenzi O. (1999) Interleukin 6 knockout mice are resistant to antigen-induced experimental arthritis. Cytokine. 11:1057\u201364.","journal-title":"Cytokine"},{"key":"1611552_CR7","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.171.6.3202","volume":"171","author":"MA Nowell","year":"2003","unstructured":"Nowell MA, et al. (2003) Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of experimental arthritis by soluble gp130. J. Immunol. 171:3202\u20139.","journal-title":"J. Immunol."},{"key":"1611552_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4049\/jimmunol.182.1.613","volume":"182","author":"MA Nowell","year":"2009","unstructured":"Nowell MA, et al. (2009) Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J. Immunol. 182:613\u201322.","journal-title":"J. Immunol."},{"key":"1611552_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/art.21537","volume":"54","author":"PK Wong","year":"2006","unstructured":"Wong PK, et al. (2006) Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum. 54:158\u201368.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR10","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P","volume":"43","author":"Z Szekanecz","year":"2000","unstructured":"Szekanecz Z, et al. (2000). Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 43:1266\u201377.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1023\/A:1007064212462","volume":"24","author":"LM Ayer","year":"2000","unstructured":"Ayer LM, Issekutz AC, Waterhouse CCM, Stadnyk AW. (2000) Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A. Inflammation. 24:447\u201361.","journal-title":"Inflammation"},{"key":"1611552_CR12","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar1458","volume":"7","author":"I Rioja","year":"2005","unstructured":"Rioja I, Clayton CL, Graham SJ, Life PF, Dickson Marion C. (2005) Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysis. Arthritis Res. Ther. 7:R101\u201317.","journal-title":"Arthritis Res. Ther."},{"key":"1611552_CR13","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.175.5.3360","volume":"175","author":"E Lubberts","year":"2005","unstructured":"Lubberts E, et al. (2005) Requirement of Il-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J. Immunol. 175:3360\u20138.","journal-title":"J. Immunol."},{"key":"1611552_CR14","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1186\/ar2553","volume":"10","author":"F Ria","year":"2008","unstructured":"Ria F, et al. (2008) Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Res. Ther. 10:R135.","journal-title":"Arthritis Res. Ther."},{"key":"1611552_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2249.2004.02499.x","volume":"137","author":"I Rioja","year":"2004","unstructured":"Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF. (2004) Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin. Exp. Immunol. 137:65\u201373.","journal-title":"Clin. Exp. Immunol."},{"key":"1611552_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1084\/jem.187.4.461","volume":"187","author":"T Alonzi","year":"1998","unstructured":"Alonzi T, et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:461\u20138.","journal-title":"J. Exp. Med."},{"key":"1611552_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1172\/JCI12724","volume":"107","author":"IK Campbell","year":"2001","unstructured":"Campbell IK, O\u2019Donnell K, Lawlor KE, Wicks IP. (2001) Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J. Clin. Invest. 107:1519\u201327.","journal-title":"J. Clin. Invest."},{"key":"1611552_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1359-6101(02)00021-7","volume":"13","author":"Y Iwakura","year":"2002","unstructured":"Iwakura Y. (2002) Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 13:341\u201355.","journal-title":"Cytokine Growth Factor Rev."},{"key":"1611552_CR19","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1002\/art.24126","volume":"58","author":"M Fujimoto","year":"2008","unstructured":"Fujimoto M, et al. (2008) Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum. 58:3710\u20139.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/art.27235","volume":"62","author":"C Lamacchia","year":"2010","unstructured":"Lamacchia C, Palmer G, Seemayer CA, Talabot-Ayer D, Gabay C. (2010) Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis Rheum. 62:452\u201362.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1172\/JCI200421795","volume":"114","author":"H Hata","year":"2004","unstructured":"Hata H, et al. (2004) Distinct contribution of IL-6, TNF-\u03b1, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J. Clin. Invest. 114:582\u20138.","journal-title":"J. Clin. Invest."},{"key":"1611552_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.coi.2005.09.017","volume":"17","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S, Sakaguchi N. (2005) Animal models of arthritis caused by systemic alteration of the immune system. Curr. Opin. Immunol. 17:589\u201394.","journal-title":"Curr. Opin. Immunol."},{"key":"1611552_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff V, et al. (1996) Organ-specific disease provoked by systemic autoreactivity. Cell. 87:811\u201322.","journal-title":"Cell"},{"key":"1611552_CR24","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/1529-0131(199912)42:12<2517::AID-ANR3>3.0.CO;2-W","volume":"42","author":"S Mangialaio","year":"1999","unstructured":"Mangialaio S, Staub A, Benoist C, Mathis D. (1999) The arthritogenic T cell receptor and its ligand in a spontaneous model of arthritis. Arthritis Rheum. 42:2517\u201323.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1084\/jem.20020439","volume":"196","author":"H Ji","year":"2002","unstructured":"Ji H, et al. (2002) Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 196:77\u201385.","journal-title":"J. Exp. Med."},{"key":"1611552_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1471-4906(02)00013-3","volume":"24","author":"G Kaplanski","year":"2003","unstructured":"Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. (2003) IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 24: 25\u201329.","journal-title":"Trends Immunol."},{"key":"1611552_CR27","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","volume":"175","author":"SA Jones","year":"2005","unstructured":"Jones SA (2005). Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175:3463\u20138.","journal-title":"J. Immunol."},{"key":"1611552_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/75068","volume":"6","author":"R Atreya","year":"2000","unstructured":"Atreya R, et al. (2000) Blockade of interleukin-6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn\u2019s disease and experimental colitis in vivo. Nat. Med. 6:583\u20138.","journal-title":"Nat. Med."},{"key":"1611552_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","volume":"268","author":"T Jostock","year":"2001","unstructured":"Jostock T, et al. (2001) Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268:160\u20137.","journal-title":"Eur. J. Biochem."},{"key":"1611552_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1074-7613(01)00151-0","volume":"14","author":"SM Hurst","year":"2001","unstructured":"Hurst SM, et al. (2001) IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 14:705\u201314.","journal-title":"Immunity"},{"key":"1611552_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","volume":"6","author":"M Romano","year":"1997","unstructured":"Romano M, et al. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:315\u201325.","journal-title":"Immunity"},{"key":"1611552_CR32","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1182\/blood-2007-01-067918","volume":"110","author":"A Chalaris","year":"2007","unstructured":"Chalaris A, et al. (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood. 110:1748\u201355.","journal-title":"Blood"},{"key":"1611552_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2007-07-102137","volume":"111","author":"B Rabe","year":"2008","unstructured":"Rabe B, et al. (2008) Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood. 111:1021\u20138.","journal-title":"Blood"},{"key":"1611552_CR34","doi-asserted-by":"publisher","first-page":"9589","DOI":"10.1073\/pnas.0501794102","volume":"102","author":"RM McLoughlin","year":"2005","unstructured":"McLoughlin RM, et al. (2005) IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. U. S. A. 102:9589\u201394.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1611552_CR35","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.4049\/jimmunol.143.8.2520","volume":"143","author":"FA Houssiau","year":"1989","unstructured":"Houssiau FA, Coulie PG, Van Snick J. (1989) Distinct roles of IL-1 and IL-6 in human T cell activation. J. Immunol. 143:2520\u20134.","journal-title":"J. Immunol."},{"key":"1611552_CR36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. (2007) Interleukins 1\u03b2_and 6 but not transforming growth factor-\u03b2 are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942\u20139.","journal-title":"Nat. Immunol."},{"key":"1611552_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1365-2249.2001.01469.x","volume":"123","author":"KA Bush","year":"2001","unstructured":"Bush KA, Walker JS, Lee CS, Kirkham WB. (2001) Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin. Exp. Immunol. 123:487\u201395.","journal-title":"Clin. Exp. Immunol."},{"key":"1611552_CR38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, et al. (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 62:383\u201391.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1196\/annals.1361.110","volume":"1051","author":"GF Ferraccioli","year":"2005","unstructured":"Ferraccioli GF, Tomietto P, De Santis M. (2005) Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases. Ann. N. Y. Acad. Sci. 1051:658\u201365.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1611552_CR40","first-page":"2336","volume":"31","author":"CA Hitchon","year":"2004","unstructured":"Hitchon CA, Alex P, Erdile LB, et al. (2004) A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J. Rheumatol. 31:2336\u201346.","journal-title":"J. Rheumatol."},{"key":"1611552_CR41","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/art.1780310614","volume":"31","author":"FA Houssiau","year":"1988","unstructured":"Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31:784\u20138.","journal-title":"Arthritis Rheum."},{"key":"1611552_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/rheumatology\/36.1.38","volume":"36","author":"JD Canete","year":"1997","unstructured":"Canete JD, et al. (1997) Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies. Br. J. Rheumatol. 36: 38\u201342.","journal-title":"Br. J. Rheumatol."},{"key":"1611552_CR43","doi-asserted-by":"publisher","first-page":"R784","DOI":"10.1186\/ar1733","volume":"7","author":"K Raza","year":"2005","unstructured":"Raza K, et al. (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7:R784\u201395.","journal-title":"Arthritis Res. Ther."},{"key":"1611552_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","volume":"21","author":"T Mima","year":"2009","unstructured":"Mima T, Nishimoto N. (2009) Clinical value of blocking IL-6 receptor. Curr. Opin. Rheumatol. 21:224\u201330.","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2010.00067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2010.00067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T23:28:02Z","timestamp":1711927682000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2010.00067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":44,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1611552"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2010.00067","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}